NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
The fightback begins: Boss of London's Queen Mary University tells pro
Tauranga bars to close earlier under booze rule changes
ancient chinese scroll sells for fifty seven million dollars
Young Boys seals 6th Swiss soccer league title in 7 years after rallying from firing coach Wicky
Hundreds of firefighters battle Western Australia wildfire
Traffic updates: Easter weekend set to begin
Shooting injures 2 at Missouri high school graduation ceremony
China's disenchanted youth 'lie flat' to cope with modern life